This compound is a benzimidazole derivative that serves as a pharmaceutical intermediate. It is primarily used in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1313020-26-6
1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester
pharmaceutical intermediate
(2E,4E,6E,8E)-3-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-7-methyl-2,4,6,8-nonatetraenoic Acid
pharmaceutical intermediate
Carbamic acid, N-[2,2-dimethyl-5-[2-(4-octylphenyl)ethenyl]-1,3-dioxan-5-yl]-, phenylmethyl ester
pharmaceutical intermediate
N(alpha)-t-butoxycarbonyl-L-leucine
pharmaceutical intermediate
Boc-L-Isoleucine
pharmaceutical intermediate
propan-2-yl 4-(5-amino-1-methylbenzimidazol-2-yl)butanoate
WNNXAWPAXNZYEF-UHFFFAOYSA-N
CC(C)OC(=O)CCCC1=NC2=C(N1C)C=CC(=C2)N
—